INTRODUCTION
Diabetes mellitus is a metabolic disorder that is presently troubling the world, posing a great socio-economic burden to very nation. An overview on the definition, diagnosis, potential dangers and current prevention and treatment options available in putting a check to this disease will go a long way in helping physicians, diabetic patients and even diabetic relatives (whom themselves have an increased risk of developing the disease) in controlling the alarming increase in the prevalence of diabetes mellitus being experienced today.
DEFINITION
The term diabetes mellitus describes a chronic metabolic disorder of multiple aetiology characterized by hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from a relative or an absolute lack in insulin. EPIDEMIOLOGY Dramatically, over the past two decades the worldwide prevalence of DM has risen from an estimated 30 million cases in 1985 to 177 million in 2000. Based on current trends, over 360 million individuals will have diabetes by the year 2030. The prevalence of both type 1 and type 2 DM is increasing worldwide, the prevalence of type 2 DM is rising much more rapidly because of increasing obesity and reduced activity levels as countries become more industrialized. With respect to sex distribution, the prevalence is similar in men and women throughout most age ranges (10.5% and 8.8% in individuals >20 years respectively) but is slightly greater in men >60 years. Worldwide estimates project that in 2030 the greatest number of individuals with diabetes will be 45-64 years of age. There exist a considerable geographic variation in the incidence of DM and this variability is likely due to genetic, behavioral, and environmental factors. Scandinavian countries have the highest incidence of type 1 DM (e.g., in Finland, the incidence is 35/100,000 per year) while the Pacific Rim has a much lower rate (in Japan and China, the incidence is 1-3/100,000 per year 
TYPE 1 DIABETES MELLITUS
Although typically diagnosed in patients before age 30, it can present at any age due to variability in the rate of beta-cell destruction.
TYPE 2 DIABETES MELLITUS
Type 2 DM is known to account for 90-95% of cases of DM globally. In Africa, DM currently affects about 10 million people in the 20-79 year age group with the figure estimated to increase to 18 million by the year 2025. The prevalence of DM in this same age group is estimated to rise from 3.5% to 4.5%.
A It is important to note that women who become pregnant and who are known to have diabetes mellitus which antedates pregnancy do not have gestational diabetes but have "diabetes mellitus and pregnancy" and should be treated accordingly before, during, and after the pregnancy. In making a diagnosis of gestational diabetes mellitus a standard OGTT should be performed after overnight fasting (8-14 hours) by giving 75 g anhydrous glucose in 250-300 ml water. Plasma glucose is measured fasting and after 2 hours. Pregnant women who meet WHO criteria for diabetes mellitus or IGT are classified as having Gestational Diabetes Mellitus. After the pregnancy ends, the woman should be re-classified as having either diabetes mellitus, or IGT, or normal glucose tolerance based on the results of a 75 g OGTT six weeks or more after delivery. It is important to note that such women, regardless of the 6-week post-pregnancy result, are at increased risk of subsequently developing diabetes. It is important to note that a form of acute onset of type 1 diabetes mellitus, termed fulminant diabetes, has been noted in Japan and may be related to viral infection of islets.
OTHER SPECIFIC TYPES

INVESTIGATIONS
MAKING A DIAGNOSIS
OGTT*--≥ 126mg/dL and 2 hours postprandial of ≥ 210mg/dL *The oral glucose tolerance test (OGTT) is principally used for diagnosis when blood glucose levels are equivocal, during pregnancy, or in epidemiological studies. 
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